Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations

Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to s...

Full description

Saved in:
Bibliographic Details
Published inBMC medical research methodology Vol. 24; no. 1; pp. 52 - 23
Main Authors Sverdlov, Oleksandr, Ryeznik, Yevgen, Anisimov, Volodymyr, Kuznetsova, Olga M., Knight, Ruth, Carter, Kerstine, Drescher, Sonja, Zhao, Wenle
Format Journal Article
LanguageEnglish
Published London BioMed Central 28.02.2024
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2288
1471-2288
DOI10.1186/s12874-023-02131-z

Cover

Abstract Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
AbstractList The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
Abstract Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize $$n=500$$ n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.BACKGROUNDThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.METHODSWe considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff.RESULTSMaximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff.The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.CONCLUSIONSThe choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
Background: The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods: We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n=500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results: Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients-which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. Conclusions: The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize [formula omitted] patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients--which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment. Keywords: Multi-center clinical trial, Maximum tolerated imbalance, Allocation randomness, Poisson-gamma model, Recruitment time
Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. Methods We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize n = 500 patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Results Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff. Conclusions The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process. We considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize [formula omitted] patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence. Maximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance-randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients--which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness-balance tradeoff. The choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
BackgroundThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers and their geographic location, the strategy for recruitment of study participants, amongst others. There are plenty of methods to sequentially randomize patients in a multi-center RCT, with or without considering stratification factors. The goal of this paper is to perform a systematic assessment of such randomization methods for a multi-center 1:1 RCT assuming a competitive policy for the patient recruitment process.MethodsWe considered a Poisson-gamma model for the patient recruitment process with a uniform distribution of center activation times. We investigated 16 randomization methods (4 unstratified, 4 region-stratified, 4 center-stratified, 3 dynamic balancing randomization (DBR), and a complete randomization design) to sequentially randomize \(n=500\) patients. Statistical properties of the recruitment process and the randomization procedures were assessed using Monte Carlo simulations. The operating characteristics included time to complete recruitment, number of centers that recruited a given number of patients, several measures of treatment imbalance and estimation efficiency under a linear model for the response, the expected proportions of correct guesses under two different guessing strategies, and the expected proportion of deterministic assignments in the allocation sequence.ResultsMaximum tolerated imbalance (MTI) randomization methods such as big stick design, Ehrenfest urn design, and block urn design result in a better balance–randomness tradeoff than the conventional permuted block design (PBD) with or without stratification. Unstratified randomization, region-stratified randomization, and center-stratified randomization provide control of imbalance at a chosen level (trial, region, or center) but may fail to achieve balance at the other two levels. By contrast, DBR does a very good job controlling imbalance at all 3 levels while maintaining the randomized nature of treatment allocation. Adding more centers into the study helps accelerate the recruitment process but at the expense of increasing the number of centers that recruit very few (or no) patients—which may increase center-level imbalances for center-stratified and DBR procedures. Increasing the block size or the MTI threshold(s) may help obtain designs with improved randomness–balance tradeoff.ConclusionsThe choice of a randomization method is an important component of planning a multi-center RCT. Dynamic balancing randomization with carefully chosen MTI thresholds could be a very good strategy for trials with the competitive policy for patient recruitment.
ArticleNumber 52
Audience Academic
Author Kuznetsova, Olga M.
Carter, Kerstine
Ryeznik, Yevgen
Anisimov, Volodymyr
Knight, Ruth
Drescher, Sonja
Zhao, Wenle
Sverdlov, Oleksandr
Author_xml – sequence: 1
  givenname: Oleksandr
  orcidid: 0000-0002-1626-2588
  surname: Sverdlov
  fullname: Sverdlov, Oleksandr
  email: alex.sverdlov@novartis.com
  organization: Novartis Pharmaceuticals Corporation
– sequence: 2
  givenname: Yevgen
  orcidid: 0000-0003-2997-8566
  surname: Ryeznik
  fullname: Ryeznik, Yevgen
  organization: Department of Pharmacy, Uppsala University
– sequence: 3
  givenname: Volodymyr
  orcidid: 0000-0003-1230-1794
  surname: Anisimov
  fullname: Anisimov, Volodymyr
  organization: Amgen Ltd
– sequence: 4
  givenname: Olga M.
  orcidid: 0000-0002-7037-3641
  surname: Kuznetsova
  fullname: Kuznetsova, Olga M.
  organization: Merck & Co., Inc
– sequence: 5
  givenname: Ruth
  orcidid: 0000-0001-6810-2845
  surname: Knight
  fullname: Knight, Ruth
  organization: Liverpool Clinical Trials Centre, University of Liverpool
– sequence: 6
  givenname: Kerstine
  orcidid: 0009-0004-6144-2344
  surname: Carter
  fullname: Carter, Kerstine
  organization: Boehringer-Ingelheim Pharmaceuticals Inc
– sequence: 7
  givenname: Sonja
  surname: Drescher
  fullname: Drescher, Sonja
  organization: Boehringer-Ingelheim Pharma GmbH & Co. KG
– sequence: 8
  givenname: Wenle
  surname: Zhao
  fullname: Zhao, Wenle
  organization: Medical University of South Carolina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38418968$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-525900$$DView record from Swedish Publication Index
BookMark eNp9kstu1DAUhiNURNuBF2CBIrFhQUp8ieOs0KgUqFSJBZet5Zw4Mx4ldrEdKubpe-ZC26lQFSWO7O__z8XnNDty3pkse03KM0Kk-BAJlTUvSsrwJYwU62fZCeE1KSiV8ujB_3F2GuOqLEktmXiRHTPJiWyEPMnG72YwkKxb5DoP2nV-tGudrHf5aNLSd3nvAx6N05BsAcYlE3IYrLOghzwFi98bm5Z5TB6WOiYLeTAQJptGhHPwLtrOhK1lfJk97_UQzav9Ost-fr74cf61uPr25fJ8flWA4FUqSMtbrqGqQVai7WtacdaVjEPfNoS0GqAlHRUGJO90reu263rSawlgmla0hM2yy51v5_VKXQc76vBXeW3VdsOHhdIBUx2MEg3jdSsbziVGpVpWTcMYsJ4T2usK0Ov9zivemOupPXD7ZH_Nt27TpCpaNWWJ-Mcdjuxouk3Hgh4OVIcnzi7Vwv9RpET5Jvgse7d3CP73ZGJSo41ghkE746eoKObHBeWEI_r2EbryU3DYWqQqIUWFOd1TC40FW9d7DAwbUzWvJaebkgVSZ_-h8OnMaPEaTW9x_0Dw5mGldyX-Gy4E6A6A4GMMpr9DSKk2E6x2E6xwgtV2gtUaRfKRCGzaTg-mY4enpWx_UxjHLUy478YTqlu2vgeq
CitedBy_id crossref_primary_10_1186_s12874_024_02340_0
crossref_primary_10_1002_ksa_12535
Cites_doi 10.1002/9780471462422.eoct301
10.1002/sim.6266
10.1002/sim.4495
10.1080/03610928308828586
10.1002/(SICI)1097-0258(19990730)18:14<1741::AID-SIM210>3.0.CO;2-F
10.1214/08-STS269
10.1002/(SICI)1097-0258(19980815/30)17:15/16<1767::AID-SIM978>3.0.CO;2-H
10.1111/biom.13447
10.1186/s12874-017-0428-z
10.1002/sim.2956
10.1002/sim.3068
10.1007/978-3-7908-2410-0_1
10.1016/j.cct.2011.08.004
10.1214/aoms/1177706973
10.1080/03610926.2022.2152286
10.1080/03610926.2011.581189
10.1002/sim.2421
10.1007/978-0-8176-4542-7_25
10.1016/j.cct/2010.05.002
10.1007/978-3-7908-1952-6_1
10.1007/978-3-030-48555-9
10.1016/j.cct.2015.11.008
10.1056/NEJM197607082950204
10.1016/j.cct.2021.106450
10.1239/aap/1013540242
10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X
10.1002/cpt1974155443
10.1186/1471-2288-11-21
10.1002/(SICI)1097-0258(19980815/30)17:15/16<1779::AID-SIM979>3.0.CO;2-7
10.1002/pst.412
10.1002/sim.4780122410
10.1002/sim.7817
10.1002/sim.5667
10.1186/s12874-021-01303-z
10.1002/sim.7206
10.2307/2529712
10.1016/0197-2456(88)90046-3
10.1016/0197-2456(88)90050-5
10.1186/1471-2288-10-63
10.1002/sim.8160
10.1016/j.cct.2015.07.010
10.1016/0021-9681(74)90015-0
10.1177/009286150303700305
10.1016/0197-2456(88)90047-5
10.1016/j.cct.2005.09.002
10.3414/me0538
10.1007/978-3-031-17820-7_23
10.1016/0197-2456(93)90013-4
10.1016/j.cct.2015.01.013
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
ACNBI
ADTPV
AOWAS
D8T
DF2
ZZAVC
DOA
DOI 10.1186/s12874-023-02131-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Uppsala universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Uppsala universitet
SwePub Articles full text
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic




Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2288
EndPage 23
ExternalDocumentID oai_doaj_org_article_69347b89448b4b2a859933c3f412fa5c
oai_DiVA_org_uu_525900
PMC10900599
A784285996
38418968
10_1186_s12874_023_02131_z
Genre Randomized Controlled Trial
Multicenter Study
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
MK0
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
2VQ
4.4
ACNBI
ADTPV
AHSBF
AOWAS
C1A
D8T
DF2
EJD
H13
HYE
IPNFZ
RIG
ZZAVC
ID FETCH-LOGICAL-c645t-1b4b4ac57c856bf72543d034cfb911baccb1d26ec84da7a7bddf1fa8cce9b6b13
IEDL.DBID M48
ISSN 1471-2288
IngestDate Wed Aug 27 01:26:43 EDT 2025
Tue Sep 09 23:24:53 EDT 2025
Thu Aug 21 18:35:02 EDT 2025
Fri Sep 05 09:05:38 EDT 2025
Sat Jul 26 00:15:39 EDT 2025
Tue Jun 17 22:16:05 EDT 2025
Tue Jun 10 21:12:45 EDT 2025
Wed Jul 30 01:47:43 EDT 2025
Thu Apr 24 23:01:23 EDT 2025
Tue Jul 01 04:31:02 EDT 2025
Sat Sep 06 07:35:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Multi-center clinical trial
Poisson-gamma model
Allocation randomness
Recruitment time
Maximum tolerated imbalance
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c645t-1b4b4ac57c856bf72543d034cfb911baccb1d26ec84da7a7bddf1fa8cce9b6b13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0009-0004-6144-2344
0000-0002-7037-3641
0000-0001-6810-2845
0000-0003-2997-8566
0000-0002-1626-2588
0000-0003-1230-1794
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12874-023-02131-z
PMID 38418968
PQID 2956865590
PQPubID 42579
PageCount 23
ParticipantIDs doaj_primary_oai_doaj_org_article_69347b89448b4b2a859933c3f412fa5c
swepub_primary_oai_DiVA_org_uu_525900
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10900599
proquest_miscellaneous_2933462414
proquest_journals_2956865590
gale_infotracmisc_A784285996
gale_infotracacademiconefile_A784285996
pubmed_primary_38418968
crossref_primary_10_1186_s12874_023_02131_z
crossref_citationtrail_10_1186_s12874_023_02131_z
springer_journals_10_1186_s12874_023_02131_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-02-28
PublicationDateYYYYMMDD 2024-02-28
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-28
  day: 28
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC medical research methodology
PublicationTitleAbbrev BMC Med Res Methodol
PublicationTitleAlternate BMC Med Res Methodol
PublicationYear 2024
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References W Zhao (2131_CR21) 2015; 41
2131_CR41
RD Hilgers (2131_CR6) 2017; 17
2131_CR42
D Blackwell (2131_CR44) 1957; 28
Y Ryeznik (2131_CR52) 2018; 37
SJ Pocock (2131_CR26) 1975; 31
WF Rosenberger (2131_CR46) 2008; 23
S Heritier (2131_CR24) 2005; 24
W Zhao (2131_CR20) 2014; 33
G Mijoule (2131_CR56) 2012; 31
J Lachin (2131_CR35) 1988; 9
2131_CR45
GF Borm (2131_CR40) 2005; 26
TM Therneau (2131_CR14) 1993; 14
YP Chen (2131_CR38) 2000; 32
A Hallstrom (2131_CR13) 1988; 9
DR Taves (2131_CR25) 1974; 15
2131_CR2
2131_CR1
2131_CR5
2131_CR7
M Zelen (2131_CR27) 1974; 27
AL Gould (2131_CR48) 1998; 17
2131_CR9
2131_CR15
2131_CR16
2131_CR17
VV Anisimov (2131_CR19) 2017; 36
2131_CR54
2131_CR11
DF Signorini (2131_CR23) 1993; 12
2131_CR12
VV Anisimov (2131_CR30) 2007; 26
JP Matts (2131_CR36) 1988; 9
HW Cai (2131_CR22) 2021; 106
R Chu (2131_CR50) 2011; 11
R Mountain (2131_CR55) 2022; 78
KD Barnard (2131_CR4) 2010; 10
2131_CR29
W Zhao (2131_CR39) 2011; 32
WF Rosenberger (2131_CR8) 2015
2131_CR28
M Morrissey (2131_CR57) 2010; 31
DJ McEntegart (2131_CR10) 2003; 37
2131_CR31
BC Kahan (2131_CR51) 2013; 32
VV Anisimov (2131_CR18) 2011; 10
O Sverdlov (2131_CR53) 2019; 38
S Senn (2131_CR3) 1998; 17
RM Pickering (2131_CR49) 2007; 26
2131_CR37
G Kundt (2131_CR43) 2009; 48
2131_CR32
2131_CR33
2131_CR34
B Jones (2131_CR47) 1998; 17
References_xml – ident: 2131_CR28
  doi: 10.1002/9780471462422.eoct301
– volume: 33
  start-page: 5239
  year: 2014
  ident: 2131_CR20
  publication-title: Stat Med
  doi: 10.1002/sim.6266
– ident: 2131_CR12
– volume: 31
  start-page: 1655
  issue: 16
  year: 2012
  ident: 2131_CR56
  publication-title: Stat Med
  doi: 10.1002/sim.4495
– ident: 2131_CR37
  doi: 10.1080/03610928308828586
– ident: 2131_CR42
  doi: 10.1002/(SICI)1097-0258(19990730)18:14<1741::AID-SIM210>3.0.CO;2-F
– volume: 23
  start-page: 404
  issue: 3
  year: 2008
  ident: 2131_CR46
  publication-title: Stat Sci
  doi: 10.1214/08-STS269
– volume: 17
  start-page: 1767
  issue: 15–16
  year: 1998
  ident: 2131_CR47
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1767::AID-SIM978>3.0.CO;2-H
– volume: 78
  start-page: 636
  issue: 2
  year: 2022
  ident: 2131_CR55
  publication-title: Biometrics
  doi: 10.1111/biom.13447
– volume: 17
  start-page: 159
  year: 2017
  ident: 2131_CR6
  publication-title: BMC Med Res Methodol.
  doi: 10.1186/s12874-017-0428-z
– volume: 26
  start-page: 4958
  issue: 27
  year: 2007
  ident: 2131_CR30
  publication-title: Stat Med
  doi: 10.1002/sim.2956
– ident: 2131_CR41
– volume: 26
  start-page: 5445
  issue: 30
  year: 2007
  ident: 2131_CR49
  publication-title: Stat Med
  doi: 10.1002/sim.3068
– ident: 2131_CR16
  doi: 10.1007/978-3-7908-2410-0_1
– volume: 32
  start-page: 953
  year: 2011
  ident: 2131_CR39
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2011.08.004
– volume: 28
  start-page: 449
  issue: 2
  year: 1957
  ident: 2131_CR44
  publication-title: Ann Math Stat
  doi: 10.1214/aoms/1177706973
– ident: 2131_CR32
– ident: 2131_CR45
  doi: 10.1080/03610926.2022.2152286
– ident: 2131_CR17
  doi: 10.1080/03610926.2011.581189
– volume: 24
  start-page: 3729
  year: 2005
  ident: 2131_CR24
  publication-title: Stat Med
  doi: 10.1002/sim.2421
– ident: 2131_CR15
– ident: 2131_CR29
  doi: 10.1007/978-0-8176-4542-7_25
– ident: 2131_CR11
– volume: 31
  start-page: 381
  year: 2010
  ident: 2131_CR57
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct/2010.05.002
– ident: 2131_CR33
  doi: 10.1007/978-3-7908-1952-6_1
– ident: 2131_CR34
  doi: 10.1007/978-3-030-48555-9
– ident: 2131_CR5
  doi: 10.1016/j.cct.2015.11.008
– ident: 2131_CR1
  doi: 10.1056/NEJM197607082950204
– volume: 106
  year: 2021
  ident: 2131_CR22
  publication-title: Contemp Clinical Trials
  doi: 10.1016/j.cct.2021.106450
– volume: 32
  start-page: 738
  year: 2000
  ident: 2131_CR38
  publication-title: Adv Appl Probab
  doi: 10.1239/aap/1013540242
– volume: 17
  start-page: 1753
  issue: 15–16
  year: 1998
  ident: 2131_CR3
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X
– volume: 15
  start-page: 443
  issue: 5
  year: 1974
  ident: 2131_CR25
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt1974155443
– volume: 11
  start-page: 21
  year: 2011
  ident: 2131_CR50
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-11-21
– volume: 17
  start-page: 1779
  issue: 15–16
  year: 1998
  ident: 2131_CR48
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1779::AID-SIM979>3.0.CO;2-7
– volume-title: Randomization in Clinical Trials: Theory and Practice
  year: 2015
  ident: 2131_CR8
– ident: 2131_CR9
– volume: 10
  start-page: 50
  issue: 1
  year: 2011
  ident: 2131_CR18
  publication-title: Pharm Stat
  doi: 10.1002/pst.412
– volume: 12
  start-page: 2343
  issue: 24
  year: 1993
  ident: 2131_CR23
  publication-title: Stat Med
  doi: 10.1002/sim.4780122410
– volume: 37
  start-page: 3056
  issue: 21
  year: 2018
  ident: 2131_CR52
  publication-title: Stat Med
  doi: 10.1002/sim.7817
– volume: 32
  start-page: 1136
  issue: 7
  year: 2013
  ident: 2131_CR51
  publication-title: Stat Med
  doi: 10.1002/sim.5667
– ident: 2131_CR2
– ident: 2131_CR7
  doi: 10.1186/s12874-021-01303-z
– volume: 36
  start-page: 1302
  issue: 8
  year: 2017
  ident: 2131_CR19
  publication-title: Stat Med
  doi: 10.1002/sim.7206
– volume: 31
  start-page: 103
  issue: 1
  year: 1975
  ident: 2131_CR26
  publication-title: Biometrics
  doi: 10.2307/2529712
– volume: 9
  start-page: 312
  year: 1988
  ident: 2131_CR35
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(88)90046-3
– volume: 9
  start-page: 375
  issue: 4
  year: 1988
  ident: 2131_CR13
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(88)90050-5
– volume: 10
  start-page: 63
  year: 2010
  ident: 2131_CR4
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-10-63
– volume: 38
  start-page: 2905
  issue: 16
  year: 2019
  ident: 2131_CR53
  publication-title: Stat Med
  doi: 10.1002/sim.8160
– ident: 2131_CR54
  doi: 10.1016/j.cct.2015.07.010
– volume: 27
  start-page: 365
  year: 1974
  ident: 2131_CR27
  publication-title: J Chronic Dis
  doi: 10.1016/0021-9681(74)90015-0
– volume: 37
  start-page: 293
  year: 2003
  ident: 2131_CR10
  publication-title: Drug Inf J
  doi: 10.1177/009286150303700305
– volume: 9
  start-page: 327
  issue: 4
  year: 1988
  ident: 2131_CR36
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(88)90047-5
– volume: 26
  start-page: 637
  issue: 6
  year: 2005
  ident: 2131_CR40
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2005.09.002
– volume: 48
  start-page: 129
  issue: 2
  year: 2009
  ident: 2131_CR43
  publication-title: Methods Inf Med
  doi: 10.3414/me0538
– ident: 2131_CR31
  doi: 10.1007/978-3-031-17820-7_23
– volume: 14
  start-page: 98
  issue: 2
  year: 1993
  ident: 2131_CR14
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(93)90013-4
– volume: 41
  start-page: 211
  year: 2015
  ident: 2131_CR21
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2015.01.013
SSID ssj0017836
Score 2.4197707
Snippet Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number...
The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of centers...
Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number...
BackgroundThe design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number of...
Background: The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the number...
Abstract Background The design of a multi-center randomized controlled trial (RCT) involves multiple considerations, such as the choice of the sample size, the...
SourceID doaj
swepub
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 52
SubjectTerms Allocation randomness
Clinical trials
Design
Evaluation
Health Sciences
Humans
Information management
Maximum tolerated imbalance
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Monte Carlo simulation
Multi-center clinical trial
Patient Selection
Patients
Poisson-gamma model
Random Allocation
Random variables
Recruitment time
Research Design
Research methodology
Sample Size
Statistical Theory and Methods
Statistics for Life Sciences
Theory of Medicine/Bioethics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICOBOEDUTfyIfVweVYVULlDUm-WnuhLNou3m0l_PjJ0sTZHKhUNyiJ2Hx-N5xDPfEPJag0_gLVYviw5OKsXaKaFqF8C-CFEwnR3F46_y6IR_ORWnV0p9YUxYgQcuhDuQmvHOKQ1uhOOutUqARmWeJd60yQqP0nehF5MzNe4fYG7ClCKj5MFFg7DuNegnOBrW1JczNZTR-v-WyVeU0vWAyd2u6TWE0ayVDu-Ru6M5SZdlGPfJrdg_ILePxw3zh-T8W65zAw-hloJaCuvzMfGSltrRFIxWaMpxhTW-OG7olC1Jc0kPir9qKdiI_swiqDMFGbkZVjk6nfqx3mf57_eInBx-_v7xqB4rLNRecrGtGyApt150XgnpUoeZ8WHBuE8OhKCz3rsmtDJ6xYPtbOdCSE2yyvuonXQNe0z2-nUfnxKahE4peCEiupi4m9hZa3Ub4PkIQVORZiK48SP8OFbB-GmyG6KkKZNkYJJMniRzWZF3u3t-FfCNG3t_wHnc9UTg7HwB2MmM7GT-xU4VeYtcYHB5w-d5O2YpwCARKMssO8UR80_LiuzPesKy9PPmiY_MKBYuTIvJmRKcuEVFXu2a8U4MdevjesA-jHEJhhWvyJPCdrshMcUbpSUQU80YcjbmeUu_Osug4RiAi1g8FXk_8e6f77qJqG8Kf89e8Wn1Y5nJOgxGtFh49tn_IP5zcqcFm7EgBuyTve1miC_A5tu6l3l5_wZnllOq
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICOBOEDUOrEd54SWR1UhlQsU7c3yK3QlmpTdzaW_nhnHSUmR9rA5rJ3H2ON52DPfEPK6Bp_AGaxeFixcVBNyq4TKrQf7wgdR1tFRPPkmj0_516VYpg23TQqrHGViFNS-c7hHflBgXpsE-_fww8WfHKtG4elqKqFxk9yK0GXAz9VycrgYZiiMiTJKHmwYgrvnoKXgx0qWX86UUcTs_18y_6OarodNTmen13BGo246ukfuJqOSLgYuuE9uhPYBuX2Sjs0fkvPvsdoNPIQaCsrJd-cp_ZIOFaQpmK7QFKMLc3xxWNMxZ5LGwh4UN2wpWIruzCC0MwVJue5XMUadulT1c9j9e0ROj778-HScpzoLuZNcbHNmueXGicopIW1TYX68Pyy5ayyIQmucs8wXMjjFvalMZb1vWGOUc6G20rLyMdlruzY8JbQRddN4J0RARxPPFCtjTF14eD4C0WSEjQOuXQIhx1oYv3V0RpTUwyRpmCQdJ0lfZuTddM_FAMGxs_dHnMepJ8Jnxz-69S-dVqOWdckrq2rwTYH2wigBZlrpyoazojHCZeQtcoHGRQ6f50zKVQAiES5LLyrFEfmvlhnZn_WExenmzSMf6SQcNvqKlTPyamrGOzHgrQ1dj33Kkkswr3hGngxsN5FUKs5ULWEw1YwhZzTPW9rVWYQOxzBcROTJyPuRd6--a9egvhn4e_aKz6ufizisfa9FgeVnn-0m9zm5U4BNOCAC7JO97boPL8Cm29qXceH-BTcZTCw
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4k2gICOBOEBEHT_iHJdCVSGVCxT1ZvmprkR30XZz6a9nxnFCU1AlDskhfiT2jD0zGc83hLzuwCbwFrOXRQc3nWLttNS1C6BfhCh5lw3Fo6_q8Fh8OZEnBSYHY2Eu---ZVh_OGQKy1yBZ4GKc1Rc3yS3JuMqOWbU_eQwwGmEMivlnu5ngyfj8f-_Cl8TQ1SOSk5_0CqZolkMH98jdokDSxUDx--RGXD0gt4-Ki_whOfuWM9tAJ9RSEERhfVZCLemQLZqCmgpF-SRhjS-OGzrGR9KcxIPiz1kKWqE_tQjjTGFX3PTLfB6d-pLhc_jT94gcH3z-vn9Yl5wKtVdCbmvmhBPWy9ZrqVxqMRY-7HHhk4Ntz1nvHQuNil6LYFvbuhASS1Z7HzunHOOPyc5qvYpPCU2ySyl4KSMaleg_bK21XROgfwSdqQgbJ9z4AjiOeS9-mmx4aGUGIhkgkslEMhcVeTe1-TXAbVxb-yPScaqJUNn5AXCQKSvPqI6L1ukO7FAYe2O1BJWMe54Ea5KVviJvkQsMLmj4PG9LXAIMEqGxzKLVAlH-OlWR3VlNWIh-XjzykSkbwblpMBxTgdm2V5FXUzG2xMNtq7jusQ7nQoEqJSryZGC7aUhcC6Y7BZOpZww5G_O8ZLU8zTDheOQW0Xcq8n7k3T_fdd2kvhn4e_aKT8sfizytfW9kg6lmn_1ft8_JnQb0wQENYJfsbDd9fAH63Na9zAv5N9QBRWo
  priority: 102
  providerName: Springer Nature
Title Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations
URI https://link.springer.com/article/10.1186/s12874-023-02131-z
https://www.ncbi.nlm.nih.gov/pubmed/38418968
https://www.proquest.com/docview/2956865590
https://www.proquest.com/docview/2933462414
https://pubmed.ncbi.nlm.nih.gov/PMC10900599
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-525900
https://doaj.org/article/69347b89448b4b2a859933c3f412fa5c
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_tQ0K8IL4JjMpIIB4gbE5sx3lAqC2bJqROaFBU8WLZTsIqbS10rQT767lzko6MaQ-N1Nhx4vPZd2ff_Q7gZY42gbeUvax0eNFVGTstdewK1C-KUqZ5MBRHR-pwLD5N5GQD2nRHDQHPrzXtKJ_UeHH67vevPx9wwr8PE16r3XNOoO0xSh_88ZTHF5uwjZJJkTE2EpenChSxEKKNMh4nidZtEM21bXQEVcDz_3_V_kdsXXWpXJ-rXsEgDXLr4C7caRRO1q855B5slLP7cGvUHKk_gLMvIRMONsIsQ8FVzM-a0ExWZ5dmqNZiUfA8jOnF5YK18ZQsJP1gtJnLUIv0J5ZgnxmuoovVNPivM99kBK13Bh_C-GD_6_AwbnIwxF4JuYy5E05YLzOvpXJVRrHzxV4qfOVwmXTWe8eLRJVei8JmNnNFUfHKau_L3CnH00ewNZvPyifAKplXVeGlLMkIpfPGzFqbJwW2TyA1EfCW4MY3AOWUJ-PUBENFK1MPksFBMmGQzEUEb9bP_KzhOW6sPaBxXNckaO1wY774YZqZalSeiszpHO1W7HtitUQVLvVpJXhSWekjeE1cYIgl8fO8beIYsJMEpWX6mRaECpirCHY6NXHi-m5xy0em5XuTUPimQjNvL4IX62J6kpzhZuV8RXXSVChkcBHB45rt1l1KteA6V0hM3WHITp-7JbPpSYAVJxddQuuJ4G3Lu5ffdRNRX9X83XnFx-m3fiDramVkQqlpn95MjWdwO0F9sUYL2IGt5WJVPkd9b-l6sJlNsh5sD_aPPh_jv6Ea9sLeSS9Mb7weD77_BfmkVos
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkai4gBRm8R2nANCW9pqS7srBG3Vm7Edh65Es2UfQvRH8RuZcR4lRdpbD5vD2nnYM56HPfMNIa8z8AmsxuplzsBFFi40ksvQ5GBf5I4nmXcUhyMxOGKfTvjJCvnT5MJgWGUjE72gzicW98g3YsxrE2D_bn44_xli1Sg8XW1KaFRsse9-_wKXbfZ-bxvoux7HuzuHHwdhXVUgtILxeRgZZpi2PLWSC1OkmA2ebybMFgYWvtHWmiiPhbOS5TrVqcnzIiq0tNZlRpgogefeIKsMM1p7ZHVrZ_T5S3tugTkRTWqOFBuzCOHkQ9CL8IuSKLzoqD9fJeB_XfCPMrwaqNme1l5BNvXacPcuuVObsbRf8d09suLK--TmsD6of0DOvvr6OvAQqimow3xyVid80qpmNQVjGZp8PGOIL3ZT2mRpUl9KhOIWMQXb1J5qBJOmIJuni7GPiqe2rjNa7Tc-JEfXQoNHpFdOSveE0IJnRZFbzh26tniKmWqtsziH5yP0TUCiZsKVrWHPsfrGD-XdHylURSQFRFKeSOoiIG_be84r0I-lvbeQjm1PBOz2f0ym31W9_pXIEpYamYE3DGOPteRgGCY2KVgUF5rbgLxBLlAoVuDzrK6zI2CQCNCl-qlkiDWYiYCsdXqCOLDd5oaPVC2OZupy8QTkVduMd2KIXekmC-yTJEyAQccC8rhiu3ZIiWSRzARMpuwwZGfM3ZZyfOrByjHwFzGAAvKu4d3L71o2qesVf3desT0-7vtpXSwUj7Hg7dPlw31Jbg0OhwfqYG-0_4zcjsEirfAI1khvPl2452BRzs2LehlT8u26JcdfpLeNfQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXVJ4NLWAkEAeIWie24xyXllV5tEKCot4sP-lKNFttdy_99cw4D5qCKnFIDvEjsT32zGRmviHkVQ06gTOYvSxYuKkYcquEyq0H-cIHUdZJUTw8kgfH_NOJOLkSxZ-83XuTZBvTgChNzXLn3Md2iyu5c8EQpj0HfgMXK1l-eZvc4cj60Fwr9wY7AsYo9KEy_2w3YkcJtf_vs_kKc7ruODlYT68hjSbuNN0g9zqxkk5aOrhPboXmAVk_7AznD8nZt5TvBjqhhgJ78vOzLgCTtjmkKQivUJT8C3N8cVjQPmqSptQeFH_ZUpAV3alBcGcKZ-ViNUte6tR1eT_b_3-PyPH0w_e9g7zLtJA7ycUyZ5ZbbpyonBLSxgoj5P1uyV20cBha45xlvpDBKe5NZSrrfWTRKOdCbaVl5WOy1sybsEloFHWM3gkRUNVEq2JljKkLD_0jFE1GWD_h2nUw5JgN45dO6oiSul0kDYuk0yLpy4y8HdqctyAcN9Z-j-s41EQA7fRgvvipu_2oZV3yyqoatFMYe2GUAEGtdGXkrIhGuIy8QSrQuM3h85zpohVgkAiYpSeV4oj9V8uMbI9qwvZ04-KejnR3PFzoAoM0JShzuxl5ORRjS3R5a8J8hXXKkksQsHhGnrRkNwypVJypWsJkqhFBjsY8Lmlmpwk8HB1xEZMnI-962v3zXTdN6uuWvkev2J_9mKRpXa20KDAB7dP_6_YFWf-6P9VfPh593iJ3CxAYW7iAbbK2XKzCMxD4lvZ52tO_AV1fUJ4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selecting+a+randomization+method+for+a+multi-center+clinical+trial+with+stochastic+recruitment+considerations&rft.jtitle=BMC+medical+research+methodology&rft.au=Sverdlov%2C+Oleksandr&rft.au=Ryeznik%2C+Yevgen&rft.au=Anisimov%2C+Volodymyr&rft.au=Kuznetsova%2C+Olga+M&rft.date=2024-02-28&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2288&rft.eissn=1471-2288&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12874-023-02131-z&rft.externalDocID=A784285996
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2288&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2288&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2288&client=summon